ID   PPMI.I.1151.1
AC   CVCL_D5X8
SY   PPMI60013
DR   Wikidata; Q127383792
RX   PubMed=34434090;
WW   https://www.ppmi-info.org/access-data-specimens/download-data
WW   https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup RBD + hyposmia.
CC   Caution: The PPMI60013 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5X9 ! PPMI.I.1151.2
OI   CVCL_D5XA ! PPMI.I.1151.3
OI   CVCL_D5XB ! PPMI.I.1151.4
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=34434090; DOI=10.3389/fnmol.2021.734273; PMCID=PMC8381147;
RA   Nguyen D., Bharat V., Conradson D.M., Nandakishore P., Wang X.-N.;
RT   "Miro1 impairment in a Parkinson's at-risk cohort.";
RL   Front. Mol. Neurosci. 14:734273.1-734273.8(2021).
//